NCM
Nantahala Capital Management Portfolio holdings
AUM
$1.41B
1-Year Return
32.9%
This Quarter Return
+0.68%
1 Year Return
+32.9%
3 Year Return
+104.34%
5 Year Return
+145.08%
10 Year Return
+443.66%
AUM
$788M
AUM Growth
-$35.9M
(-4.4%)
Cap. Flow
+$36.1M
Cap. Flow
% of AUM
4.58%
Top 10 Holdings %
Top 10 Hldgs %
45.27%
Holding
137
New
21
Increased
29
Reduced
37
Closed
17
Top Buys
| 1 |
Assertio
ASRT
|
$12M |
| 2 |
America's Car Mart
CRMT
|
$11.4M |
| 3 |
Zevra Therapeutics
ZVRA
|
$11.1M |
| 4 |
Peloton Interactive
PTON
|
$9.05M |
| 5 |
Neuropace
NPCE
|
$7.74M |
Top Sells
| 1 |
The Bancorp
TBBK
|
$13.2M |
| 2 |
AUTL
Autolus Therapeutics
AUTL
|
$10.2M |
| 3 |
Pathward Financial
CASH
|
$7.8M |
| 4 |
Soleno Therapeutics
SLNO
|
$7.6M |
| 5 |
MediaAlpha
MAX
|
$7.51M |
Sector Composition
| 1 | Healthcare | 53.65% |
| 2 | Consumer Discretionary | 13.83% |
| 3 | Financials | 9.32% |
| 4 | Communication Services | 8.18% |
| 5 | Technology | 5.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Taysha Gene Therapies
TSHA
$917M
| – | – |
-1,251,139
| Closed | -$827K |
|
127
United Therapeutics
UTHR
$18.1B
| – | – |
-15,700
| Closed | -$3.47M |
|
128
SPDR S&P Biotech ETF
XBI
$5.39B
| – | – |
0
| – | – |
|
129
Zoom
ZM
$25B
| – | – |
0
| – | – |
|
|
BACK
130
DELISTED
IMAC Holdings, Inc. Common Stock
BACK
| – | – |
-1,797
| Closed | -$5.93K |
|
|
CBAY
131
DELISTED
Cymabay Therapeutics
CBAY
| – | – |
-553,307
| Closed | -$6.06M |
|
|
KRTX
132
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| – | – |
0
| – | – |
|
|
EBET
133
DELISTED
EBET, INC. Common Stock
EBET
| – | – |
-35,514
| Closed | -$126K |
|
|
BGRY
134
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
| – | – |
-500,000
| Closed | -$705K |
|
|
EAR
135
DELISTED
Eargo, Inc. Common Stock
EAR
| – | – |
-54,002
| Closed | -$266K |
|
|
MACK
136
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| – | – |
-111,148
| Closed | -$1.37M |
|